Article
Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers.
Lung cancer (Amsterdam, Netherlands) - 1 May 2022
Mc Leer Anne, Foll Matthieu, Brevet Marie, Antoine Martine, Novello Silvia, Mondet Julie, Cadranel Jacques, Girard Nicolas, Giaj Levra Matteo, Demontrond Pierre, Audigier-Valette Clarisse, Letouzé Eric, Lantuéjoul Sylvie, Fernandez-Cuesta Lynnette, Moro-Sibilot Denis
Abstract excerpt
INTRODUCTION: Among the different mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors (TKIs) reported in EGFR-mutated lung adenocarcinoma (EGFR-LUAD) patients, histological transformation into small cell carcinoma (SCLC) occurs in 3-14% of resistant cases, regardless of the generation of EGFR-TKI. In recent studies, bi-allelic inactivation of TP53 and RB1 has been identified in a vast majority of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
